F 901318

Drug Profile

F 901318

Alternative Names: F901318

Latest Information Update: 21 Jun 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator F2G
  • Class Antifungals; Piperazines; Pyrimidines; Pyrroles; Small molecules
  • Mechanism of Action Dihydroorotate dehydrogenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Aspergillosis
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Mycoses
  • Phase I/II Aspergillosis
  • Preclinical Coccidioidomycosis

Most Recent Events

  • 05 Jun 2018 Phase-II clinical trials in Mycoses in Spain (PO) (EudraCT2017-001290-17)
  • 21 Apr 2018 Preclinical trials in Coccidioidomycosis in United Kingdom (PO)
  • 21 Apr 2018 Pharmacodynamics data from a preclinical trial in Coccidioidomycosis presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID-2018)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top